There are so many small caps with much higher market caps without any sales and some still pre clinical trials if you look over the ASX. Do your own research but it seems investors are not buying the story here which could be mean OSL are doing a very poor job in this area which is definitely having an impact.
They have lost credibility here because not long ago they said there would be no need for funds until the end of the next calendar year and not long after they announced another CR into high impact news. Whether it was all a coincidence with timing , well you be the judge on that.
If the 35 million sell order was so enthused to sell why does it cancel at the end of the day. Why not leave it there so it remains higher in the queue. Something is not right here. If you think it is a level playing field your living in the twilight zone.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)